More on FOLD
Data
Financials
Upcoming Events
News
Click line-items for a historical chart and %
| Net loss | -141.4M |
| Non-cash interest expense | 1.74M |
| Depreciation and amortization | |
| Amortization of non-cash compensation | |
| Stock-based compensation - employees | 13.09M |
| Stock-based compensation - non-employees | |
| Stock-based license payments | |
| Change in fair value of warrant liability | |
| Loss on disposal of asset | |
| Impairment of leasehold improvements | |
| Non-cash charge for in-process research and development | |
| Debt instrument convertible beneficial conversion feature | |
| Prepaid expenses and other current assets | -2.8M |
| Other non-current assets | -660K |
| Accounts payable and accrued expenses | -2.92M |
| Deferred revenue | |
| Net cash used in operating activities | |
| Sale and redemption of marketable securities | 165.5M |
| Purchases of marketable securities | -199.83M |
| Purchases of property and equipment | -5.52M |
| Net cash provided by/(used in) investing activities | |
| Proceeds from the issuance of preferred stock, net of issuance costs | |
| Proceeds from the issuance of common stock and warrants, net of issuance costs | |
| Proceeds from the issuance of convertible notes | |
| Payments of capital lease obligations | |
| Payments of secured loan agreement | 0 |
| Proceeds from exercise of stock options | 1.46M |
| Proceeds from exercise of warrants (common and preferred) | |
| Proceeds from capital asset financing arrangement | |
| Proceeds from secured loan agreement | 0 |
| Net cash provided by/(used in) financing activities | |
| Net increase/(decrease) in cash and cash equivalents | -36.37M |
| Cash and cash equivalents at beginning of period | 69.49M |
| Cash and cash equivalents at end of period | 33.12M |
| Cash paid during the period for interest | 284K |
| Conversion of notes payable to preferred stock | |
| Conversion of preferred stock to common stock | |
| Accretion of redeemable convertible preferred stock | |
| Beneficial conversion feature related to the issuance of Series C redeemable convertible preferred stock | |
Entities mentioned with FOLD
- FDA | View Related Stories »
- Twitter | View Related Stories »
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- 13G | View Related Stories »
- JPMorgan | View Related Stories »
- Cowen & Co | View Related Stories »
- Robert W Baird | View Related Stories »
- Show More...
